Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

LRRK2 kinase plays a critical role in manganese-induced inflammation and apoptosis in microglia
Judong Kim, Edward Pajarillo, Asha Rizor, et al.
PLoS ONE (2019) Vol. 14, Iss. 1, pp. e0210248-e0210248
Open Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

The Pathogenesis of Parkinson's Disease: A Complex Interplay Between Astrocytes, Microglia, and T Lymphocytes?
Adina N. MacMahon Copas, Sarah F. McComish, Jean M. Fletcher, et al.
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 128
LRRK2 and idiopathic Parkinson’s disease
Emily M. Rocha, Matthew T. Keeney, Roberto Di Maio, et al.
Trends in Neurosciences (2022) Vol. 45, Iss. 3, pp. 224-236
Open Access | Times Cited: 105
ERK1/2 in immune signalling
Richard M. Lucas, Lin Luo, Jennifer L. Stow
Biochemical Society Transactions (2022) Vol. 50, Iss. 5, pp. 1341-1352
Open Access | Times Cited: 81
LRRK2 regulation of immune-pathways and inflammatory disease
Rebecca L. Wallings, Malú G. Tansey
Biochemical Society Transactions (2019) Vol. 47, Iss. 6, pp. 1581-1595
Open Access | Times Cited: 125
The effects of manganese overexposure on brain health
Mahfuzur R. Miah, Omamuyovwi M. Ijomone, Comfort O. A. Okoh, et al.
Neurochemistry International (2020) Vol. 135, pp. 104688-104688
Open Access | Times Cited: 102
Preventing Parkinson’s Disease: An Environmental Agenda
Briana R. De Miranda, Samuel M. Goldman, Gary W. Miller, et al.
Journal of Parkinson s Disease (2021) Vol. 12, Iss. 1, pp. 45-68
Open Access | Times Cited: 66
SIRT1/FOXO3-mediated autophagy signaling involved in manganese-induced neuroinflammation in microglia
Dongying Yan, Yuqing Yang, Jing Lang, et al.
Ecotoxicology and Environmental Safety (2023) Vol. 256, pp. 114872-114872
Open Access | Times Cited: 26
LRRK2 regulates ferroptosis through the system Xc‐GSH–GPX4 pathway in the neuroinflammatory mechanism of Parkinson's disease
Zijian Zheng, Shushan Zhang, Xinjie Liu, et al.
Journal of Cellular Physiology (2024) Vol. 239, Iss. 5
Open Access | Times Cited: 10
Manganese in autism spectrum disorder and attention deficit hyperactivity disorder: The state of the art
Michael Aschner, Airton C. Martins, Gustavo H. Oliveira‐Paula, et al.
Current Research in Toxicology (2024) Vol. 6, pp. 100170-100170
Open Access | Times Cited: 8
Biotin mitigates the development of manganese-induced, Parkinson’s disease–related neurotoxicity in Drosophila and human neurons
Yunjia Lai, Pablo Reina-Gonzalez, Gali Maor, et al.
Science Signaling (2025) Vol. 18, Iss. 870
Closed Access | Times Cited: 1
Dietary Antioxidants and Parkinson’s Disease
Hana Park, Amy Ellis
Antioxidants (2020) Vol. 9, Iss. 7, pp. 570-570
Open Access | Times Cited: 68
Manganese Accumulation in the Brain via Various Transporters and Its Neurotoxicity Mechanisms
Ivan Nyarko‐Danquah, Edward Pajarillo, Alexis Digman, et al.
Molecules (2020) Vol. 25, Iss. 24, pp. 5880-5880
Open Access | Times Cited: 61
The industrial solvent trichloroethylene induces LRRK2 kinase activity and dopaminergic neurodegeneration in a rat model of Parkinson's disease
Briana R. De Miranda, Sandra L. Castro, Emily M. Rocha, et al.
Neurobiology of Disease (2021) Vol. 153, pp. 105312-105312
Open Access | Times Cited: 50
The role of microglial LRRK2 kinase in manganese-induced inflammatory neurotoxicity via NLRP3 inflammasome and RAB10-mediated autophagy dysfunction
Edward Pajarillo, Sang Hoon Kim, Alexis Digman, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 7, pp. 104879-104879
Open Access | Times Cited: 22
Kinases control of regulated cell death revealing druggable targets for Parkinson’s disease
Heba M. Mansour, Ahmed F. Mohamed, Aiman S. El‐Khatib, et al.
Ageing Research Reviews (2023) Vol. 85, pp. 101841-101841
Closed Access | Times Cited: 21
Pesticides and the Microbiome-Gut-Brain Axis: Convergent Pathways in the Pathogenesis of Parkinson’s Disease
Kristína Kulcsarová, Corinna Bang, Daniela Berg, et al.
Journal of Parkinson s Disease (2023) Vol. 13, Iss. 7, pp. 1079-1106
Open Access | Times Cited: 20
LRRK2 kinase inhibition protects against Parkinson's disease-associated environmental toxicants
Neda M. Ilieva, Eric K. Hoffman, Mohammed Ghalib, et al.
Neurobiology of Disease (2024) Vol. 196, pp. 106522-106522
Open Access | Times Cited: 7
PKA- and Ca2+-dependent p38 MAPK/CREB activation protects against manganese-mediated neuronal apoptosis
Ganlin Zhu, Yiming Liu, Ye Zhi, et al.
Toxicology Letters (2019) Vol. 309, pp. 10-19
Closed Access | Times Cited: 44
The transcription factor REST up-regulates tyrosine hydroxylase and antiapoptotic genes and protects dopaminergic neurons against manganese toxicity
Edward Pajarillo, Asha Rizor, Deok-Soo Son, et al.
Journal of Biological Chemistry (2020) Vol. 295, Iss. 10, pp. 3040-3054
Open Access | Times Cited: 44
Impact of environmental toxicants on p38- and ERK-MAPK signaling pathways in the central nervous system
Omamuyovwi M. Ijomone, Joy D. Iroegbu, Michael Aschner, et al.
NeuroToxicology (2021) Vol. 86, pp. 166-171
Open Access | Times Cited: 36
Allosteric Inhibition of Parkinson’s-Linked LRRK2 by Constrained Peptides
Leah G. Helton, Ahmed Soliman, Felix von Zweydorf, et al.
ACS Chemical Biology (2021) Vol. 16, Iss. 11, pp. 2326-2338
Open Access | Times Cited: 35
LRRK2 as a target for modulating immune system responses
Isabella Russo, Luigi Bubacco, Elisa Greggio
Neurobiology of Disease (2022) Vol. 169, pp. 105724-105724
Open Access | Times Cited: 24
Mechanisms of manganese-induced neurotoxicity and the pursuit of neurotherapeutic strategies
Edward Pajarillo, Ivan Nyarko‐Danquah, Alexis Digman, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 23
Efficacy of a benzothiazole‐based LRRK2 inhibitor in oligodendrocyte precursor cells and in a murine model of multiple sclerosis
Rocío Benítez‐Fernández, Fernando Josa‐Prado, Estefanía Sánchez, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 5
Leucine-rich repeat kinase-2 (LRRK2) modulates microglial phenotype and dopaminergic neurodegeneration
Zach Dwyer, Chris Rudyk, Ashley Thompson, et al.
Neurobiology of Aging (2020) Vol. 91, pp. 45-55
Open Access | Times Cited: 38
Page 1 - Next Page

Scroll to top